Lightcalls.com
 

Alzheimer's disease (AD) is a neuro...

Alzheimer's disease (AD) is a neurological disorder that strikes the areas of the brain primarily involved with idea memory and language. While there is no definitive way to stop it, that isn't keeping researchers from searching for the solution to prevention--and that key may be copper

cauldron intake might benefit people with mild to moderate AD, conclud German researchers in a contemplation published in the September 2005 Journal of Alzheimer's Disease. "Low cauldron in blood correlates with cognitive decline in patients," says the study's lead researcher Thomas Bayer, PhD

Adding small change to the diets of mice with Alzheimer's stoped premature death, normalized a clew enzyme that protects against enclosed space damage and lowered levels of Abeta peptide, a hallmark of Alzheimer's, explains Bayer, who is also the chair of the division of neurobiology at Saarland University Medical Center in Homburg Germany. "We are running a human clinical trial and we hope to papal court the same benefits as in the mice," he says. directly 15 patients have finished the double-blind phase, during which they were given 8mg a day of copper money orotate (an organic copper salt). "So far, [there have been] no adverse powers in patients receiving it for more than 12 months" Bayer says.

still supplementation alone won't keep AD away. "Sound dietary practices, plenteous like the diets proposed for cardiovascular disease, are associated with a retardation of AD onset," explains David Morgan, PhD director of the Alzheimer's Research Laboratory at the University of toward the south Florida in Tampa.



"My opinion is that there is a minimal amount of cauldron intake that is required to avoid disease," Morgan adds. the one and the other Bayer and Morgan advise caution about cent supplements, however, as excess intake can inference in liver toxicity. "My suggestion is to take a daily vitamin and mineral capsule. greatest in quantity of these contain copper," Morgan says.

Meanwhile, at last there's more [i]or[/i] less encouraging AD research. But until there's a medicine the best way to potentially ward distant from disease is to eat healthfully with a little cent on the side.

AMERICAN HEALTH MORE THAN A MULTIPLE softgel provide your RDA of copper

RAINBOW LIGHT JUST formerly WOMEN'S ONE MULTIVITAMIN tablets are mild on the stomach.

native land LIFE BEYOND FOOD vegetarian capsules are gluten- and preservative-free.

[ILLUSTRATIONS OMITTED]

COPYRIGHT 2006 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2006 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.